Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on KdAKR Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116103255A details engineered KdAKR mutants for high-yield synthesis of tert-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, offering superior stereoselectivity and thermal stability for statin production.